Search results
An FDA change to vaccine authorization allowed Pfizer and Moderna to apply for BA.5 booster approval...
Fortune via Yahoo Finance· 2 years agoOn Monday, Pfizer asked the U.S. Food and Drug Administration for emergency authorization for the...
FDA Panel Recommends Pfizer & Moderna COVID Jabs for Young Kids
Zacks via Yahoo Finance· 2 years agoThe FDA VRBPAC committee unanimously recommends the approval of both Pfizer and BioNTech and...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 2 weeks agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
FDA Authorizes Pfizer And Moderna COVID Vaccines For Children Under 5
HuffPost via Yahoo News· 2 years agoThe Food and Drug Administration on Friday approved Pfizer and Moderna COVID-19 vaccines for...
Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market
Investor's Business Daily· 1 year agoModerna stock rose Wednesday after the biotech said its experimental RSV vaccine proved nearly 84%...
FDA greenlights updated mRNA Covid vaccines
Politico via Yahoo News· 8 months agoThe FDA on Monday cleared two updated mRNA Covid-19 shots from Pfizer-BioNTech and Moderna, paving the way for an early fall rollout. It will be the...
Pfizer 'surprised' by Moderna COVID-19 vaccine patent lawsuit
Yahoo Finance· 2 years agoModerna (MRNA) said Friday it is suing Pfizer and BioNTech (PFE/BNTX), alleging the rival drug...
Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View
Zacks via Yahoo Finance· 3 months agoModerna, Inc. MRNA reported earnings of 55 cents per share in the fourth quarter of 2023, beating...
Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older...
Benzinga via Yahoo Finance· 11 months agoModerna Inc (NASDAQ: MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to...
Pharma Stock Roundup: LLY's Donanemab Gets FDA's CRL, MRNA RSV Jab Study Succeeds
Zacks via Yahoo Finance· 1 year agoFDA gives CRL to Lilly's (LLY) Alzheimer's candidate, donanemab. Moderna's (MRNA) phase III study on...
